Dehydroepiandrosterone and Pregnenolone Alterations in Schizophrenia-Reference-Cited by-同舟云学术

Dehydroepiandrosterone and Pregnenolone Alterations in Schizophrenia

Published:2008 Issue: Volume: Page:251-297
ISSN:
Container-title:Neuroactive Steroids in Brain Function, Behavior and Neuropsychiatric Disorders
language:
Short-container-title:

Author:

Ritsner Michael S.,Gibel Anatoly,Ratner Yael,Weizman Abraham

Publisher

Springer Netherlands

Link

http://link.springer.com/content/pdf/10.1007/978-1-4020-6854-6_14.pdf

Reference241 articles.

1. Baulieu EE, Robel P. Dehydroepiandrosterone and dehydroepiandrosterone sulfate as neuroactive neurosteroids. J Endocrinol 1996; 150(Suppl):221–239.

2. Mao X, Barger SW. Neuroprotection by dehydroepiandrosterone-sulfate: role of an NFkappaB-like factor. Neuroreport 1998; 9:759–763.

3. Friess E, Schiffelholz T, Steckler T, Steiger A. Dehydroepiandrosterone–a neurosteroid. Eur J Clin Invest 2000; 30(Suppl 3):46–50.

4. Wen S, Dong K, et al. Treatment with dehydroepiandrosterone sulfate increases NMDA receptors in hippocampus and cortex. Eur J Pharmacol 2001; 430:373–374.

5. Johnson M, Bebb R, Sirrs S. Uses of DHEA in aging and other disease states. Ageing Res Rev 2002; 1:29–41.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Retinoid Receptors to Treat Schizophrenia: Rationale and Progress to Date;CNS Drugs;2016-03-11

2. Contribution of sex hormones to gender differences in schizophrenia: A review;Asian Journal of Psychiatry;2015-12

3. Sex hormones and oxytocin augmentation strategies in schizophrenia: A quantitative review;Schizophrenia Research;2015-11

4. Pregnenolone treatment reduces severity of negative symptoms in recent-onset schizophrenia: An 8-week, double-blind, randomized add-on two-center trial;Psychiatry and Clinical Neurosciences;2014-02-18

5. The Retinoid X Receptor Agonist Bexarotene Relieves Positive Symptoms of Schizophrenia;The Journal of Clinical Psychiatry;2013-12-15